We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company seeks to replace pulse oximeters to measure oxygen levels of sepsis, trauma, and cardiac surgery patients who are “on the verge of organ failure.”
An independent committee of the UK’s National Institute for Health and Care Excellence (NICE) has proposed that England’s National Health System (NHS) use hybrid closed-loop systems for managing difficult to control blood glucose levels in type 1 diabetics.
The European Commission has extended the transition period for manufacturers to comply with the Medical Devices Regulation (MDR), citing the limited capacity of notified bodies to ensure “a successful transition to the new regulatory framework.”
The European Commission has extended the transition period for manufacturers to comply with the Medical Devices Regulation (MDR), citing the limited capacity of notified bodies to ensure “a successful transition to the new regulatory framework.”
The Center for Devices and Radiological Health (CDRH) issued 39 final guidances in 2022, nearly doubling the 21 issued the previous year, but it was a Feb. 23 draft rule that garnered the most attention — Medical Devices; Quality System Regulation Amendments — that proposes to align the 20-year-old FDA quality system requirements (QSR) with International Organization for Standardization (ISO) requirements.
The U.S. Patent and Trademark Office has granted Reperio Health a patent for the technology that powers its biometric health screening platform that delivers home-performed medical tests to a mobile app.
With user fee legislation now firmly in place, a new Congress ready to begin legislating in 2023, and an omnibus package signed into law funding the FDA for another year, we talked with Steven Grossman, executive director of the Alliance for a Stronger FDA, about the big issues that face the agency as we head into the new year.